|
The
investment comes just four months after the company raised $18
million to expand in Asia-Pacific, and Lynch said the additional
funds were needed to fuel growth.
The company was one of Lynch's first investments after he left
Hewlett-Packard Co in 2012 in an acrimonious split over the $11
billion acquisition of Autonomy.
HP is suing Lynch and a former colleague for more than $5
billion over their management of Autonomy. Lynch has said he
would launch a counter claim.
Darktrace takes a different approach from other anti-virus
software that seeks to police a boundary around networks.
Instead, he said Darktrace sits inside the network, and through
machine learning recognizes abnormal activity and identifies
malignant behavior, a process analogous to how the immune system
works in the body.
"The business is growing exponentially," Lynch said.
The company, headquartered in Cambridge, England, and San
Francisco, has seen it technology deployed in 104 companies, and
it has partnered 63 other providers, such as BT for use in their
own platforms.
Darktrace has not released figures, but it said its revenue was
growing at more than 100 percent a year.
Lynch said there had been little progress in the HP cases. "It's
moving at a speed that make a glacier look like it's been taking
anabolic steroids," he said.
(Reporting by Paul Sandle, editing by David Evans)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
